HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Type 1 Spherocytosis

An autosomal dominant form of hereditary spherocytosis that is characterized by the presence of SPHEROCYTES on the peripheral blood smear. Patients often present with ANEMIA; JAUNDICE and SPLENOMEGALY, resulting in complications that may include CHOLELITHIASIS; HEMOLYSIS, and aplastic crises. Caused by mutations in the ANK1 gene. OMIM: 182900
Also Known As:
Spherocytosis, Type 1; Congenital Spherocytic Hemolytic Anemia; Congenital Spherocytosis; SPH1; Spherocytic Anemia; Spherocytosis, Hereditary, 1
Networked: 81 relevant articles (2 outcomes, 5 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Anemia
2. Cytopenia
3. Pyruvate Kinase Deficiency of Red Cells
4. Hemolytic Anemia
5. Splenomegaly

Experts

1. Jiang, Haobo: 5 articles (01/2022 - 07/2014)
2. Wang, Yang: 5 articles (01/2022 - 07/2014)
3. Lu, Zhiqiang: 2 articles (01/2020 - 07/2014)
4. Timoney, J F: 2 articles (12/2016 - 02/2004)
5. Hartson, Steven D: 1 article (01/2022)
6. Jin, Qiao: 1 article (01/2022)
7. Benedit, María: 1 article (10/2020)
8. Cervera Bravo, Áurea: 1 article (10/2020)
9. Darnaude, María Teresa: 1 article (10/2020)
10. Panizo Morgado, Elena: 1 article (10/2020)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Type 1 Spherocytosis:
1. ChromatinIBA
2. Serine Proteases (Serine Protease)IBA
3. Peptide Hydrolases (Proteases)FDA Link
4. DNA (Deoxyribonucleic Acid)IBA
5. Melanins (Melanin)IBA
6. Pyruvate KinaseIBA
7. Phosphoglycerate Mutase (Phosphoglyceromutase)IBA
8. Phenytoin (Dilantin)FDA LinkGeneric
9. IsoenzymesIBA
10. Antimicrobial PeptidesIBA

Therapies and Procedures

1. Splenectomy
2. Therapeutics
3. Surgical Instruments (Clip)
4. Cholecystectomy
5. Blood Transfusion (Blood Transfusions)